These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36399340)

  • 1. Evaluation of Industry Payments to US Advanced Practice Clinicians in 2021.
    Singh A; Hyman MJ; Modi PK
    JAMA Netw Open; 2022 Nov; 5(11):e2242869. PubMed ID: 36399340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic distribution of general industry payments to advanced-practice clinicians.
    Sun QW; Cavallo JJ; Forman HP
    Health Aff Sch; 2023 Jul; 1(1):qxad011. PubMed ID: 38756828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of industry payments to psychiatrists and psychiatric advanced practice clinicians in the USA, 2021: a cross-sectional study.
    Havlik J; Ososanya L; Lee MS; Wahid S; Heyang M; Sun QW; Ross JS; Rhee TG
    BMJ Open; 2024 Feb; 14(2):e081252. PubMed ID: 38331855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Industry-Dermatologist Financial Relationship: Insight From the Open Payment Data.
    Feng H; Wu P; Leger M
    JAMA Dermatol; 2016 Dec; 152(12):1307-1313. PubMed ID: 27706478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Advanced Practice Nurses Receiving Top Industry Payments and Their Practice Settings: a Cross-sectional Study.
    Grundy Q; Held F; Hart D; Baugh CM; Ladd E; Campbell E; Bero L
    J Gen Intern Med; 2024 May; 39(7):1142-1148. PubMed ID: 37962732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Industry Payments to Urologists and Urologic Advanced Practice Providers in 2021.
    Reed S; Singh A; Hyman MJ; Meltzer DO; Sales AE; Skolarus TA; Modi PK
    Urology; 2023 Oct; 180():121-129. PubMed ID: 37517679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Types and Distribution of Payments From Industry to Physicians in 2015.
    Tringale KR; Marshall D; Mackey TK; Connor M; Murphy JD; Hattangadi-Gluth JA
    JAMA; 2017 May; 317(17):1774-1784. PubMed ID: 28464140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan.
    Saito H; Ozaki A; Sawano T; Shimada Y; Tanimoto T
    JAMA Netw Open; 2019 Apr; 2(4):e192834. PubMed ID: 31026027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan.
    Sawano T; Ozaki A; Saito H; Shimada Y; Tanimoto T
    JAMA Netw Open; 2019 May; 2(5):e193817. PubMed ID: 31099864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Industry Payments to Medical Oncologists in the United States Since the Inception of the Open Payments Program, 2014 to 2019.
    Tarras ES; Marshall DC; Rosenzweig K; Korenstein D; Chimonas S
    JAMA Oncol; 2021 Mar; 7(3):440-444. PubMed ID: 33377904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing Consulting Fee Payments to Interventional Radiologists in the United States From Industry, 2014 to 2018: Analysis of the Open Payments Database.
    Kolarich AR; Pang S; Solomon AJ; England RW; Georgiades C
    J Am Coll Radiol; 2021 Dec; 18(12):1668-1674. PubMed ID: 34418340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional analysis of pharmaceutical payments to Japanese board-certified gastroenterologists between 2016 and 2019.
    Murayama A; Kamamoto S; Kawashima M; Saito H; Yamashita E; Tanimoto T; Ozaki A
    BMJ Open; 2023 Apr; 13(4):e068237. PubMed ID: 37072354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019.
    Murayama A; Hoshi M; Saito H; Kamamoto S; Tanaka M; Kawashima M; Mamada H; Kusumi E; Sapkota B; Shrestha S; Shrestha R; Bhandari D; Sawano T; Yamashita E; Tanimoto T; Ozaki A
    Respiration; 2022; 101(12):1088-1098. PubMed ID: 36353778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014-2017.
    Rahman MW; Trivedi NU; Bach PB; Mitchell AP
    J Natl Compr Canc Netw; 2021 Dec; 20(13):1-9. PubMed ID: 34965511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin.
    Hartung DM; Johnston K; Cohen DM; Nguyen T; Deodhar A; Bourdette DN
    JAMA Netw Open; 2018 Jun; 1(2):e180482. PubMed ID: 30646086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reasons Why Physicians and Advanced Practice Clinicians Work While Sick: A Mixed-Methods Analysis.
    Szymczak JE; Smathers S; Hoegg C; Klieger S; Coffin SE; Sammons JS
    JAMA Pediatr; 2015 Sep; 169(9):815-21. PubMed ID: 26146908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between physician characteristics and payments from industry in 2015-2017: observational study.
    Inoue K; Blumenthal DM; Elashoff D; Tsugawa Y
    BMJ Open; 2019 Sep; 9(9):e031010. PubMed ID: 31542759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis.
    Ozaki A; Saito H; Onoue Y; Sawano T; Shimada Y; Somekawa Y; Tsuji A; Tanimoto T
    BMJ Open; 2019 Sep; 9(9):e028805. PubMed ID: 31494604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-sectional analysis of financial relationships between board certified allergists and the pharmaceutical industry in Japan.
    Murayama A; Senoo Y
    BMC Med Ethics; 2024 Feb; 25(1):22. PubMed ID: 38378633
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.